Skip to main content
Sadhana Nitrochem Ltd. logo

Sadhana Nitrochem Ltd. — Investor Relations & Filings

Ticker · SADHNANIQ ISIN · INE888C01040 BSE.NS Manufacturing
Open in API
Filings indexed 837 across all filing types
Latest filing 2021-03-31 Regulatory Filings
Country IN India
Listing BSE.NS SADHNANIQ

About Sadhana Nitrochem Ltd.

https://www.sncl.com

Sadhana Nitrochem Ltd. specializes in the manufacture of chemical intermediates and performance chemicals. The company's core product portfolio includes nitrobenzene and its downstream derivatives such as metanilic acid, aniline 2,5 disulphonic acid, and sodium meta nitrobenzene sulphonate. These products serve as critical raw materials for the global dyes, pigments, pharmaceuticals, and agrochemicals sectors. The company operates advanced manufacturing facilities focused on high-purity chemical synthesis and process optimization. Its technical capabilities extend to specialized chemical reactions including nitration, hydrogenation, and sulfonation. By maintaining a vertically integrated production model, the company ensures consistent quality and supply chain reliability for its international client base across various industrial applications.

Recent filings

Filing Released Lang Actions
As per the Securities and Exchange Board of India (Prohibition of Insider Trading) (Second Amendment) Regulation, 2019, effective July 25,2019 and pursuant to Company's Code of Conduct ....
Regulatory Filings Classification · 95% confidence The document is a notification to the Bombay Stock Exchange about the closure of the trading window for insiders due to the upcoming declaration of audited financial results for the quarter and financial year ending March 31, 2021. It references regulatory compliance with SEBI's insider trading regulations and the company's code of conduct. The document does not contain any financial data or results itself, nor does it announce the results. It is a regulatory announcement related to trading restrictions ahead of financial results disclosure. The document length is short (1787 characters), and it serves as an official notification rather than a report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS).
2021-03-31 English
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on March ....
Regulatory Filings Classification · 100% confidence The document is a disclosure under regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. It details the pledge (encumbrance) of shares by a promoter entity, including specifics about the number of shares, percentage of share capital, the entity in whose favor shares are pledged, and the purpose of the borrowing. The document is a regulatory disclosure about share encumbrance and does not contain financial statements, earnings data, or management discussion. It is not an announcement of a report publication but a formal regulatory filing required by SEBI for substantial acquisition or encumbrance of shares. Therefore, it fits best under Regulatory Filings (RNS).
2021-03-25 English
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 24, 2021 for Manekchand ....
Regulatory Filings Classification · 100% confidence The document is a disclosure under regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. It details the pledge (encumbrance) of shares by a promoter entity, including specifics about the number of shares, percentage of share capital, the entity in whose favor shares are pledged, and the purpose of the borrowing. The document is a regulatory disclosure about share encumbrance and does not contain financial statements, earnings data, or management discussion. It is not an announcement of a report publication but a formal regulatory filing required by SEBI for substantial acquisition or encumbrance of shares. Therefore, it fits best under Regulatory Filings (RNS).
2021-03-25 English
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, Sadhana Nitro Chem Limited ('the Company') had intimated your good office on ....
Regulatory Filings Classification · 95% confidence The document is an intimation letter addressed to the Bombay Stock Exchange under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It informs about the launch and operational phases of a new product plant by the company. The content is a regulatory disclosure about a business update rather than a financial report or detailed presentation. The document length is short (2877 characters) and it is an announcement of an event rather than a report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-03-19 English
This is in reference to your e-mail dated 3rd March, 2021 having reference no. L/SURV/ONL/PV/GS/ 2020-2021 / 387. We would like to inform you that the Company complies with SEBI (Listing ....
Regulatory Filings Classification · 95% confidence The document is a letter from Sadhana Nitro Chem Limited to the BSE Limited regarding clarification on price movement of the company's shares. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and mentions a press note from the Government of India approving the company under a Production Linked Incentive Scheme. The letter clarifies that the price movement is market-driven and not due to undisclosed information. The document is a regulatory communication responding to a stock exchange query, providing clarifications and attaching a government press note. It does not contain financial statements, audit results, or detailed financial data. It is not a report itself but a regulatory filing clarifying market movements and compliance. Therefore, it fits best under Regulatory Filings (RNS).
2021-03-03 English
This is in reference to your e-mail dated 3rd March, 2021 having reference no. L/SURV/ONL/PV/GS/ 2020-2021 / 387. We would like to inform you that the Company complies with SEBI (Listing ....
Regulatory Filings Classification · 95% confidence The document is a letter from Sadhana Nitro Chem Limited to the BSE Limited's surveillance department clarifying the reasons behind a significant price movement of the company's shares. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, mentions a press release about production linked incentives, and states that the price movement is market-driven. The document is a regulatory communication clarifying market activity and compliance, not a financial report, earnings release, or any detailed financial disclosure. It is also short (2539 characters) and serves as a clarification letter rather than a report or announcement of a report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory communications that do not fit other specific categories.
2021-03-03 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.